Should you keep taking aspirin for a chronic brain bleed?
Part of Brain & nervous system, Heart & circulation, Injuries & trauma clinical trials.
This trial looks at whether people with a chronic subdural hematoma (a slow bleed on the brain) who are not having surgery should keep taking aspirin or stop it. It aims to find out which approach is safer and helps the hematoma heal better.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 years or older.
- You have been diagnosed with a chronic subdural hematoma (a gradual blood collection on the brain) through a CT scan or MRI.
- Your doctor has decided to manage your hematoma without surgery for now.
- You are currently taking aspirin regularly.
- You are not taking other blood thinners or anti-clotting drugs that cannot be paused.
- You do not have a bleeding disorder like hemophilia or very low platelets.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial compares two surgical techniques—using a small endoscope (camera) versus a single burr hole—to drain blood from a chronic subdural hematoma (a slow bleed on the brain surface). The goal is to see which method leads to better recovery and fewer complications.
This trial compares restarting a blood thinner early (within a few days) versus later (after about a week) in people who have a chronic subdural hematoma drained and also have atrial fibrillation. The goal is to find out which timing helps prevent both new bleeding and blood clots.
This trial compares a newer, less invasive treatment (embolization) with traditional surgery to treat chronic subdural hematoma (a slow bleed on the brain). It aims to see which approach works better and has fewer side effects.
This trial tests whether a medicine called tranexamic acid (which helps blood clot) can help your body reabsorb a subdural hematoma, a type of bleeding on the brain, without needing surgery. If successful, this treatment could reduce the need for surgery and improve recovery.
This trial studies a procedure called middle-meningeal-artery embolization, which blocks the blood supply to a chronic subdural hematoma (a slow-growing blood collection around the brain). It compares outcomes in people with one-sided versus both-sided bleeds, and aims to see if this less invasive treatment can help reduce the need for surgery or improve recovery.
This trial is testing a new, step-by-step care plan (called an enhanced recovery pathway) for people who need a small hole drilled in their skull to drain a slow-growing blood clot (chronic subdural hematoma). The goal is to see if this organized approach helps patients recover faster and feel better.
Hear when a new Chronic Subdural Hematoma trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.